{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:12:11Z","timestamp":1787235131481,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Christian Larsen and Judge Ellen Larsens Foundation"},{"name":"Program for Clinical Research Infrastructure"},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cmi.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T02:48:24Z","timestamp":1523414904000},"page":"87-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pyelonephritis in persons after age 50 as a clinical marker of urogenital cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"K.K.","family":"S\u00f8gaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Veres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Djurhuus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.T.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.04.003_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/519268","article-title":"Population-based epidemiologic analysis of acute pyelonephritis","volume":"45","author":"Czaja","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.04.003_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1186\/s12879-014-0639-4","article-title":"Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study","volume":"14","author":"Buonaiuto","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.04.003_bib3","first-page":"132","article-title":"Incidental diagnosis of uterine cancer on 99mTc-dimercaptosuccinic acid renal scintigraphy","volume":"8","author":"Kraft","year":"2005","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.cmi.2018.04.003_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.urology.2008.03.049","article-title":"Ipsilateral synchronous neoplasms of kidney presenting as acute pyelonephritis and bladder metastasis","volume":"73","author":"Tsai","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.cmi.2018.04.003_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/cas.12127","article-title":"Urinary tract infection increases subsequent urinary tract cancer risk: a population-based cohort study","volume":"104","author":"Sun","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cmi.2018.04.003_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/aje\/kwh014","article-title":"History of urinary tract infection and risk of renal cell carcinoma","volume":"159","author":"Parker","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2018.04.003_bib7","first-page":"839","article-title":"Urinary tract diseases and bladder cancer risk: a case-control study","volume":"18","author":"Jhamb","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cmi.2018.04.003_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/bjc.2014.601","article-title":"Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study","volume":"112","author":"Vermeulen","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cmi.2018.04.003_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjc.6604889","article-title":"Urinary tract infections and reduced risk of bladder cancer in Los Angeles","volume":"100","author":"Jiang","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cmi.2018.04.003_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MOU.0000000000000369","article-title":"The role of prostatic inflammation in the development and progression of benign and malignant diseases","volume":"27","author":"Gandaglia","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.cmi.2018.04.003_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.urolonc.2006.10.002","article-title":"Chronic inflammation and bladder cancer","volume":"25","author":"Michaud","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.cmi.2018.04.003_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00428-015-1820-x","article-title":"Chronic inflammation in urothelial bladder cancer","volume":"467","author":"Nesi","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cmi.2018.04.003_bib13","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12641","article-title":"Increased susceptibility to bladder inflammation in smokers: targeting the PAF\u2013PAF receptor interaction to manage inflammatory cell recruitment","volume":"3","author":"Marentette","year":"2015","journal-title":"Physiol Rep"},{"key":"10.1016\/j.cmi.2018.04.003_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cmi.2018.04.003_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cmi.2018.04.003_bib16","first-page":"535","article-title":"The Danish Cancer Registry\u2013history, content, quality and use","volume":"44","author":"Storm","year":"1997","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.cmi.2018.04.003_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.cmi.2018.04.003_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/iju.12959","article-title":"Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: implications for sex disparities","volume":"23","author":"Richards","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.cmi.2018.04.003_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1464-410X.2012.11661.x","article-title":"Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?","volume":"112","author":"Henning","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.cmi.2018.04.003_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.urology.2008.01.086","article-title":"Patterns of hematuria referral to urologists: does a gender disparity exist?","volume":"72","author":"Johnson","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.cmi.2018.04.003_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/oxfordjournals.aje.a113768","article-title":"Urinary tract infection and risk of bladder cancer","volume":"119","author":"Kantor","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2018.04.003_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12879-016-1608-x","article-title":"Risk and outcome of pyelonephritis among renal transplant recipients","volume":"16","author":"Graversen","year":"2016","journal-title":"BMC Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18303380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18303380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:21:37Z","timestamp":1761117697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18303380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1198743X18303380"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.04.003","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyelonephritis in persons after age 50 as a clinical marker of urogenital cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}